Generic drug sector surges, Haichen Pharmaceutical leads the gains

MaticHoleFiller · 2026-03-28T09:21:51+00:00

March 27 News: The generic drug sector performed strongly, with several stocks such as Wanbangde hitting the daily limit. Investment should be cautious; information is for reference only and does not constitute investment advice.

MaticHoleFiller

2026-03-28 09:21:51

Abstract generation in progress

March 27 news, as of 11:15, the generic drug sector surged, with Wanbangde hitting the daily limit, and stocks like Haichen Pharmaceutical, Shutaishen, Kelun Pharmaceutical, Xinlitai, and Hengrui Medicine seeing significant gains.

Statement: The market is risky, and investment should be cautious. This article is automatically published based on a third-party database and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to actual announcements for any discrepancies. If you have any questions, please contact biz@staff.sina.com.cn.

Massive information and precise interpretation can be found in the Sina Finance APP

责任编辑：小浪快报

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes